Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BE Group initiates process to centralize warehouse and production operations to Norrköping and the closure of the warehouse in Malmö

BE Group is initiating a process to centralize warehouse and production operations in Sweden to the site in Norrköping. The intention, related to this change, is to close the warehouse in Malmö which will affect approximately 15 employees. MBL negotiations will start as soon as possible. This change will lead to a stronger customer offering including, but not limited to, more complete deliveries, optimized production planning, more efficient use of material and logistics management with inbound and outbound deliveries to and from one warehouse. The centralization of the warehouse and

The Schock Prizes reward the creation of theories, art and music

Rolf Schock saw beauty in logic and philosophy, as well as mathematics, art and music. This year, his prizes are being awarded to two Swedish logicians, a Russian mathematician, a Belgian artist and architect and a Hungarian composer. The prize is worth 400,000 kronor per category, a total of 1.6 million Swedish krona.The Rolf Schock Prizes have an unusually large breadth. The foundation that was created after the death of Rolf Schock decides who will receive the prizes, in partnership with no fewer than three Swedish academies, the Royal Swedish Academy of Sciences, the Royal Academy of

Continued strong development in NOTE during the first quarter of 2020

NOTE continues to develop strongly despite the concerns about the spread of the Coronavirus. For the last two weeks, the production at NOTE's plant in China has been running at full capacity. With a loss of sales in the quarter of about SEK 20 million, primarily caused by an extended production stoppage in China, sales in Q1 are estimated to amount to SEK 460-470 million, corresponding to a growth of about 15%. Despite the loss of sales and additional costs in connection with the prolonged production shutdown at the plant in China, the operating margin is still expected to continue to

Nomination Committee's proposal for election of Board members

The Nomination Committee of Bioservo Technologies AB (publ) has decided to propose to the Annual General Meeting the following proposals for the number of Board members and the election of Board members. The Nomination Committee proposes that the number of Board members on the Board should be six (6). The Nomination Committee proposes, for the period until the end of the next Annual General Meeting, re-election of the Board members Anders Lundmark, Runar Bjørklund, Karin Ruiz, Kunal Pandit and Nikolaj Sørensen, as well as new election of Claes Mellgren. As the Chairman of the Board, it is

Bactiguard launches product that protects against Coronavirus

Bactiguard launches HYDROCYN aqua®, a water-based product that has been proven to have a powerful effect on killing previous variants of coronavirus within 15–30 seconds. Previous experience shows that the proven effect can be transferred to new variants of coronavirus and tests on COVID-19 (SARS-CoV-2) are now underway at the Karolinska Institute to verify this.“As a result of the rapid spread of COVID-19 in both Europe and the Middle East, we see a strong interest in HYDROCYN aqua, a water-based product that kills bacteria, fungi and virus in seconds without damaging or irritating the

Positive results from Swedish study with DiviTum in metastatic breast cancer published in prestigious journal

Uppsala, Sweden, March 12, 2020. Biovica, active in cancer diagnostics, today announced that results from a study by researchers at Lund University have been published in the well renowned journal Scientific Reports, a journal from Nature. The results support that the blood test DiviTum can be used as a prognostic tool for evaluating treatment outcomes in metastatic breast cancer.The study evaluated thymidine kinase activity in 142 women with newly diagnosed metastatic breast cancer as a tool for first-line prognosis and monitoring. Activity was measured by Biovica's DiviTum test at

Endomines Signs Concentrate Sale Agreement

Endomines AB, Stock Exchange Release 12 March 2020 at 08:30 CETEndomines AB (the “Company” or “Endomines”) is pleased to announce that it has signed an agreement with H&H Metals for the sale of gold concentrates produced from the Company’s Friday Mine (the “Project”) located in Idaho, USA, with an initial 20 WMT trial lot expected to be delivered in March, 2020. The total annual concentrate supply to H&H Metals is expected to contain between 12,000 and 15,000 ounces of payable gold. The Company will earn a 95% payable amount based on the gross value of the concentrate at spot prices, net of

Epiroc publishes Annual and Sustainability Report for 2019

Stockholm, Sweden: Epiroc, a leading productivity partner for the mining and infrastructure industries, today published its Annual and Sustainability Report for 2019.The report describes Epiroc’s second year as an independent company, when it further enhanced its innovative solutions in such areas as automation, digitalization and electrification. Epiroc’s revenues, profit and cash flow increased, supported by strong growth of the aftermarket and efficiency initiatives. The report also highlights Epiroc’s focus on safety, energy efficiency and other sustainability aspects. The report is

#20-89 Stressed market conditions on all equity and index derivatives

A state of stressed market conditions has been decided for all equity and index derivatives. Stressed market conditions will remain until further notice. When stressed market is called for it means that market makers are allowed to quote prices with a larger spread than normal.Please check our website www.ngm.se for information regarding the affected instruments. For further information concerning this NGM notice please contact: NGM market surveillance, +46 8 566 390 55, marketsurveillance@ngm.se Nordic Growth Market NGM AB About NGM Nordic Growth Market NGM AB (NGM) is an

Neste sets an ambitious target for carbon neutral production by 2035

Neste Corporation, Press Release, 12 March 2020 at 9.05 a.m. (EET) Neste is committed to reaching carbon neutral production by 2035. The commitment complements Neste’s other strategic climate commitment of reducing customers’ greenhouse gas emissions  by at least 20 million tons annually by 2030. “Neste’s purpose is to create a healthier planet for our children. We do this by offering renewable and circular solutions to our customers. But what

Precautionary measures to reduce risks of infectivity at Gunnebo’s Annual General Meeting 2020

Gunnebo is closely monitoring the current status of the covid-19, corona virus. In the light of the decision by the Public Health Agency of Sweden to raise the risk level for infectivity, Gunnebo will take certain precautions during the Annual General Meeting which will be held at 4 p.m. CET on Tuesday 21 April, 2020, at Elite Park Avenue Hotel in Gothenburg.The following precautions will be made to the arrangement: · No food or refreshments will be served. · The registration will open at 3.30 p.m. CET, i.e. 30 minutes before the opening of the Annual General Meeting. · Gunnebo’s

Inhalation Sciences receives new PreciseInhale order from Karolinska Institutet

The Institute of Environmental Medicine at Karolinska Institutet is one of the world’s most innovative pulmonary research bodies, and a returning ISAB customer. It has now signed a 45.000 euro order for an eight-month lease of a PreciseInhale platform, with a purchase option at the end of the period.The new order was signed on Wednesday March 11, March 2020 with Institute of Environmental Medicine (IMM), Associate Professor Mikael Adner. IMM has a long history of collaboration with ISAB. It has already previously purchased one PreciseInhale aerosol generating platform, as well as an

Update on Phase III GY004 trial for cediranib

12 March 2020 07:00 GMT   Update on Phase III GY004 trial for cediranib added toLynparza in platinum-sensitive relapsed ovarian cancer   The trial did not meet the primary endpoint of progression-free survival vs. platinum-based chemotherapy   AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced high-level results from the Phase III GY004 trial, led by NRG Oncology and sponsored by the US National Cancer Institute (NCI), that examined primarily the efficacy and safety of the potential new medicine

29 MW Wärtsilä power plant brings reliable electricity supply to Iraqi port operations

Wärtsilä Corporation, Trade press release, 12 March 2020 at 9 am EETA 29 MW gas-fuelled power plant supplied by the technology group Wärtsilä to the Umm Qasr Ports Authority Zone in Basra, Iraq, commenced commercial operations in February. The plant ensures availability of a reliable supply of electricity to the port’s operations, which had previously been subject to frequent power interruptions. The Wärtsilä plant was ordered in October 2018 by Lebanon-based Butec, the engineering, procurement and construction (EPC) provider for the project. Butec was contracted by Prime Metro Power

YIT’s Annual General Meeting on March 12, 2020: Kari Kauniskangas, President and CEO: “Our positive development continued in 2019”

YIT Corporation                                        Investor news                                           March 12, 2020, at 9:00 a.m.YIT Corporation holds its Annual General Meeting in Helsinki today, March 12, 2020, at 10:00 a.m. In his review to the General Meeting, President and CEO Kari Kauniskangas will present YIT’s financial statements for 2019 and the outlook for 2020. As published earlier in the 2019 financial statements bulletin, YIT expects its full-year adjusted operating profit to be in the range of EUR 150–190 million. “Our positive development continued in 2019. The

Notice of Annual General Meeting of Gunnebo AB (publ)

The Annual General Meeting (the “AGM”) of Gunnebo AB (publ), Reg. No. 556438-2629, will be held at 4 p.m. CET on Tuesday, 21 April, 2020, at Elite Park Avenue Hotel in Gothenburg, Sweden. Registration starts at 3.30 p.m. CET.Participation In order to be entitled to participate, shareholders who wish to attend the AGM must       be recorded in the register of shareholders maintained by Euroclear Sweden AB on Wednesday, 15 April, 2020, and must       notify the company of their intention to attend the AGM no later than Wednesday, 15 April, 2020 (preferably before 4 p.m. CET), on the

Cloetta´s Annual report 2019 available on the website

Cloetta´s annual report 2019 has today been published on Cloetta´s website.The annual report, which also includes the sustainability report, can be downloaded at http://www.cloetta.com/annualreport2019 The financial year covers the period from 1 January to 31 December 2019. This information is information that Cloetta AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted, by the below contact person, for publication on 12 March 2020 at 8:00 am CET.

Castellum takes measures to reduce risk of spreading Covid-19 virus at March 19 AGM

Transmission speed of the Covid-19 (corona) virus remains difficult to assess, and Castellum is closely following developments. With a view to shielding the health of shareholders, Board members and co-workers, several new decisions have been made regarding the company’s Annual General Meeting, scheduled for March 19, 2020.The Swedish Public Health agency instructions for limiting general contagion include avoiding larger public events, and when these cannot be avoided, minimizing time spent as well as avoiding crowding situations and other interactions with many people. As a cautionary and

Neste Capital Markets Day 2020: Creating profitable growth through renewable and circular solutions

Neste Corporation, Press Release, 12 March 2020 at 9 a.m. (EET) Neste is holding a Capital Markets Day 2020 as a webcast today, 12 March 2020. It will feature presentations by President and CEO Peter Vanacker as well as senior management on subjects such as the company's strategy, market outlook and the next steps for creating profitable growth through renewable and circular solutions. Excellent progress in strategy execution ‒ renewed vision and values Neste is in a strong position for the second wave of growth and transformation. The company has an excellent safety and

Telia Company’s Annual and Sustainability Report 2019 is now available at www.teliacompany.com

The combined report can be downloaded as a printer-friendly pdf and is available in English and Swedish. The report is also available as a digital one-pager report.    For more information, please contact our press office +46 771 77 58 30, visit our Newsroom  or follow us on Twitter @Teliacompany .    We’re Telia Company, the New Generation Telco. Our approximately 21,000 talented colleagues serve millions of customers every day in one of the world’s most connected regions. With a strong connectivity base,

Redeye: EG7 (Toadman Interactive) - A Growing Pipeline

Redeye raises estimates and valuation somewhat on the back of positive forecast adjustments. We are excited about the pipeline and the acquisition of the EvilvEvil projects from Leyou, which we view as an attractive component of managements’ growth strategy. Read more and download the research update: http://bit.ly/38ORICJ Start following companies at Redeye to receive the latest equity research within Life Science and Technology. This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/

Live Webcast of the announcement of RP101 Phase II clinical results

Redwood Pharma and Prof. Gerhard Garhöfer of the Medical University of Vienna, Austria invite you to listen to the live presentation at 10:30 am CET today March 12, 2020 of the results of the RP101 Phase II clinical trial following this morning’s formal press release. The presentation will be held at the location: Kungstornen Konferens center, Kungsgatan 33, 2 tr, 111 56 Stockholm. To view the webcast and ask questions, please follow the link: https://www.finwire.tv/webcast/redwood-pharma/12mars/ Webcast viewers can submit questions for the presenters via the webcast.

RP101 demonstrates efficacy and safety in Phase II study of patients with moderate-to-severe dry eye disease

· RP101 more than doubles tear fluid production · Fast onset: statistically significant efficacy after just 14 days · All objective and subjective parameters show improvement Stockholm, Sweden, March 12, 2020 - Redwood Pharma announces today significant improvement of objective and subjective endpoints in the Phase II study in postmenopausal women with moderate-to-severe dry eye. RP101 more than doubles tear fluid production. The objective Schirmer test reached 9.6 mm compared to the nominal 10 mm goal for the primary endpoint. Further objective and subjective endpoints demonstrate

There are no items matching the current filter
There are no more items matching the current filter
Back to top